FDA clears first generics of Pfizer/BMS’ anticoagulant Eliquis
WEBDec 24, 2019 · The FDA has approved the first two generics of Pfizer and Bristol-Myers Squibb’s blockbuster anticoagulant drug Eliquis, from Micro Labs and Mylan. FDA approval doesn’t necessarily mean that the generics will be made available anytime soon, as Pfizer and BMS are claiming patent protection for several more years, but …
Pfizer’s pentavalent meningococcal vaccine granted FDA approval
WEBOct 23, 2023 · Pfizer’s Penbraya has been approved by the US Food and Drug Administration (FDA) as the first pentavalent vaccine that provides protection against the five most common serogroups causing meningococcal disease in individuals aged ten to 25 years. Meningococcal disease is an uncommon but serious illness that can lead to death within 24 hours ...
Communique - PMLiVE
WEBCommuniqué – Volume 53. New insights in health comms innovation. Communiqué Awards 2022 – winners’ case studies. INSIGHTS – Demonstrating impact • Driving behaviour change.
Novo Nordisk announces positive phase 2 trial results for type 2 ...
WEBAug 23, 2022 · Commenting on the positive results, Martin Holst Lange, executive vice president for development at Novo Nordisk, said: “We are encouraged by the impressive phase 2 results for CagriSema in people with type 2 diabetes. The results indicate that CagriSema reduces blood sugar more than semaglutide alone and …
Valneva and Pfizer initiate phase 3 Lyme disease vaccine study
WEBAug 9, 2022 · Valneva and Pfizer have announced the initiation of a phase 3 study to investigate the efficacy, safety and immunogenicity of their Lyme disease candidate VLA15. VLA15 is the only Lyme disease vaccine candidate currently in clinical development. The vaccine uses a mechanism that targets the outer surface protein A of …
Moderna shares positive phase 3 results for mRNA influenza …
WEBSep 15, 2023 · Moderna has shared positive results from a late-stage trial of its influenza vaccine, with mRNA-1010 shown to generate a stronger immune response against all four World Health Organization (WHO)-recommended flu strains compared to GSK’s Fluarix. Improved immunogenicity was observed across age …
Novartis restructures organisation to support growth and …
WEBApr 4, 2022 · Novartis has revealed its plans for the launch of a new organisational structure and operating model designed to support its innovation, growth, and product development goals as a focused medicines organisation over the next ten years. Key to the restructure is the integration of the pharmaceuticals and oncology business units, which will be ...
How do you define a biotech company? - PMLiVE
WEBOct 6, 2017 · Investopedia defines a biotech company in this way; a company that uses live organisms or their products, such as bacteria or enzymes, to manufacture drugs. Whereas pharmaceutical companies use only chemical – and generally artificial – materials to create drugs. Johnson & Johnson and Pfizer are two of the largest pharma companies in the ...
Encouraging patient participation in real-world studies
WEBJun 17, 2020 · By Bill Row, Bruce Capobianco and Maggie Adamski. With a variety of sources available, including electronic health records and devices to collect data directly from patients, real-world data (RWD) is rapidly becoming the latest frontier for life sciences companies in supporting regulatory filings and conducting drug safety surveillance.
About us - PMLiVE
WEBBUSINESS DIRECTORTara Lovegrove Email: [email protected] Tel: +44 (0)1372 414 242. BUSINESS DEVELOPMENT. Eliot Haynes – Key Account Manager Email: [email protected] Tel: +44 (0)1372 414 220. EXECUTIVE DIRECTORKarl Equi Email: [email protected] Tel: +44 (0)1372 414 270. ADDRESSPMGroup Worldwide Ltd Mansard House Church Road Little Bookham ...